The severity features of artharagra clinical course in metabolic syndrome

Kayumov U.K; D.T. Khatamova; M.L.  Saipova; G.M. Khamidova; M.M. Ziyamukhammedova

doi:10.47494/mesb.2020.6.119

The severity features of artharagra clinical course in metabolic syndrome

(1) Kayumov U.K Tashkent institute of postgraduate medical education, Tashkent, Uzbekistan
Uzbekistan
(2) D.T. Khatamova Tashkent institute of postgraduate medical education, Tashkent, Uzbekistan
Uzbekistan
(3) M.L. Saipova Tashkent institute of postgraduate medical education, Tashkent, Uzbekistan
Uzbekistan
(4) G.M. Khamidova Tashkent institute of postgraduate medical education, Tashkent, Uzbekistan
Uzbekistan
(5) M.M. Ziyamukhammedova Tashkent institute of postgraduate medical education, Tashkent, Uzbekistan
Uzbekistan
(*) Corresponding Author

DOI:

https://doi.org/10.47494/mesb.2020.6.119

Keywords:

metabolic syndrome, artharagra, severity index, hyperglycemia

Abstract

A few studies have been devoted to the metabolic syndrome and insulin resistance study in artharagra, which showed the syndrome presence and its characteristic insulin resistance in the overwhelming patients’ number. Only a few studies have reported on the insulin resistance effect and hyperinsulinemia on the artharagra course, in particular on the articular syndrome and other clinical disease manifestations. Nevertheless, they showed a high incidence of metabolic syndrome and its characteristic insulin resistance in the vast majority patients with artharagra.

A direct relationship was revealed between the individual metabolic syndrome components, in particular, insulin resistance and hyperinsulinemia, and the hyperuricemia severity, which is accompanied by a more severe artharagray arthritis course in patients with artharagra.

Downloads

Download data is not yet available.

References

Barskova V.G., Nasonova V.A. Arthragra and insulin resistance syndrome // Russian med. journal. 2003. T.P., № 23. p. 1299-1301.

Sukhikh J.L., Shtonda M.V., Arthragra - modern aspects of diagnosis and treatment. Clinical medicine,2011 №3

Arthragra. Clinical guidelines АРР 2016.

Byrne, C. D. Themetabolicsyndrome / C. D. Byrne, S. H. Wild. Chichester, 2005.-418 p

Chen S.Y., Chen C.L., Shen M.L. et al. Trends in the manifestations of artharagra in Taiwan. Rheumatology (Oxford). 2003; 42:1529–1533.

Metabolic syndrom and ischemic heart disease in artharagra / J. Vazquez-Mellado et al. // J. Clin. Reumatol. 2004. V. 10, 3. P. 105-109.

Miller, M. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome / M. Miller, J. Rliyne, H. Chen // Arch. Med. Res. 2007. - V. 38, № 4. - P. 444-451.

View article

Published

2020-11-18

How to Cite

Kayumov U.K, D.T. Khatamova, M.L. Saipova, G.M. Khamidova, & M.M. Ziyamukhammedova. (2020). The severity features of artharagra clinical course in metabolic syndrome. Middle European Scientific Bulletin, 6, 76-79. https://doi.org/10.47494/mesb.2020.6.119

Download Citation

Issue

Vol. 6 (2020): November

Section

Political Science

This work is licensed under a Creative Commons Attribution 4.0 International License.

The work simultaneously licensed under a Creative Commons Attribution 4.0 International License

You are free to:

Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.